Lindis Blood Care GmbH
PrivateLast Round
Follow-on Offering
Dec 12, 2024
Company Overview
Lindis Blood Care GmbH operates in Healthcare & Life Sciences and is based in Hennigsdorf. Its latest recorded funding round was a VC Round in February 2022.
Lindis Blood Care GmbH is a medical technology company developing CATUVAB®, a medical device designed to remove EpCAM-positive cancer cells from intraoperative blood to enable autologous blood transfusions during oncological surgeries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lindis Blood Care GmbH Comparables
Compare Lindis Blood Care GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HemoClear B.V. | 82% | |
| i-SEP | 76% | |
| Brightwake Ltd | 73% |
For institutional investors. Book with your work email.
Lindis Blood Care GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Dec 12, 2024 | ||||
| VC Round | Feb 9, 2022 | ||||
| Series A | Dec 13, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lindis Blood Care GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Series A |
| Brandenburg Kapital | Series A, VC Round, Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2024
Brandenburg Kapital led the round with participation from Franzpeter Bracht and Horst Lindhofer.
For institutional investors. Book with your work email.
Lindis Blood Care GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lindis Blood Care GmbH's valuation, stock price, and market status.
Is Lindis Blood Care GmbH a public or private company?
Lindis Blood Care GmbH is a private company.
What is the current stock price of Lindis Blood Care GmbH?
Lindis Blood Care GmbH is a private company, so its shares have no public market price. Caplight tracks Lindis Blood Care GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lindis Blood Care GmbH worth (valuation)?
Valuation information for Lindis Blood Care GmbH is not publicly available.
Can I buy Lindis Blood Care GmbH stock?
Lindis Blood Care GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lindis Blood Care GmbH's last funding round?
Lindis Blood Care GmbH's most recent funding round was Follow-on Offering on December 12, 2024.
Who are the main investors in Lindis Blood Care GmbH?
Key investors in Lindis Blood Care GmbH include Brandenburg Kapital.
Will Lindis Blood Care GmbH IPO soon?
No public IPO plans have been announced for Lindis Blood Care GmbH.
How can I track Lindis Blood Care GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Lindis Blood Care GmbH's shares on secondary markets.